ADA, EASD Release Update on Management of Hyperglycemia in Type 2 Diabetes
September 23, 2022

The new consensus recommends holistic, person centered care focused on glycemic and weight management, CV risk reduction, and cardiorenal organ protection.

USPSTF Issues Recommendations on Lifestyle Change Counseling to Prevent CVD
July 27, 2022

The USPSTF guidance supports shared decision making with patients without CVD risk factors who may benefit from behavioral counseling on diet and physical activity.

Time-restricted Eating Could Improve Glucose Homeostasis, Other Metabolic Measures in Patients with Type 2 Diabetes
July 26, 2022

Food consumption confined to a 10-hour period for adults with T2D led to increased time in range and lowered nocturnal and fasting glucose.

Efpeglenatide is Safe, Effective in Treatment-naïve Patients with Type 2 Diabetes: AMPLITUDE-M Findings
July 25, 2022

The GLP-1 RA given once weekly to T2D patients with hyperglycemia not controlled by diet and exercise lowered HbA1c to ≤6.5% in approximately half the study population.

Risks for Diabetes and CVD Spike in Early COVID-19 Infection, May Diminish Over 12 Months
July 22, 2022

Type 1 diabetes diagnoses increased by 81% during the 4-week acute phase of COVID-19 in UK patients and CVD diagnoses rose 6-fold, according to a large population-based study.

Impact of Social Determinants of Health on Key Cardiometabolic Measures Amplified by New Research
July 19, 2022

Social determinants of health, including education and income level and race/ethnicity, are drivers of declining cardiometabolic health in the US, says investigator Meghan O'Hearn.

Intermediate Cardiometabolic Risk: Study Author Explains this "Critical Inflection Point"
July 18, 2022

Americans sitting on the cusp of cardiometabolic disease, ie, with prediabetes, prehypertension, overweight but not obesity, need intervention, now.

11 Cardiology Highlights for Primary Care, January to June, 2022
July 14, 2022

These 11 studies of cardiovascular and metabolic disease prevention, assessment, and treatment were top trending topics on Patient Care in the first half of 2022.

US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
July 13, 2022

US prevalence of optimal cardiometabolic health has declined as poor levels have risen significantly over 2 decades. Investigator Meghan O'Hearn, MS, details the research.

Diabetes Patients on Medicare Advantage Plans May Not Receive Optimal Care
July 08, 2022

Medicare Advantage plans may cut treatment corners to avoid more costly but more effective and targeted therapy for diabetes patients.